TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to ...

A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...

Researchers probed what psychologists call the ‘paradox of effort’ to learn how different people value work they could do in ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...